Minimization of administration route errors with subcutaneous rituximab
نویسندگان
چکیده
منابع مشابه
The Rate of Physicochemical Incompatibilities, Administration Errors. Factors Correlating with Nurses᾽ Errors
AbstractMedication errors are commonly encountered in hospital setting. Intravenous medications pose particular risks because of their greater complexity and the multiple steps required in their preparation, administration and monitoring. We aimed to determine the rate of errors during preparation and administration phase of intravenous medications and the correlation of these errors with the d...
متن کاملThe Rate of Physicochemical Incompatibilities, Administration Errors. Factors Correlating with Nurses᾽ Errors
AbstractMedication errors are commonly encountered in hospital setting. Intravenous medications pose particular risks because of their greater complexity and the multiple steps required in their preparation, administration and monitoring. We aimed to determine the rate of errors during preparation and administration phase of intravenous medications and the correlation of these errors with the d...
متن کاملChemical disbudding of goat kids with subcutaneous administration of synthetic eugenol: Histopathology and morphometry
This study was conducted to evaluate the effect of subcutaneous administration of synthetic eugenol (EG) for disbudding of goat kids, as a new chemical method. Thirty apparently healthy Raieni (Cashmere) goat kids (five-day-old) were divided randomly into six groups (n = 5). In the pathology (P) groups (P3, P8 and P60 according to the sample collection day after...
متن کاملA Canadian perspective on the subcutaneous administration of rituximab in non-Hodgkin lymphoma.
Rituximab is widely used for the treatment of non-Hodgkin lymphoma, being a key component in most therapeutic regimens. Administration of the intravenous (IV) formulation is lengthy and places a significant burden on health care resources and patient quality of life. A subcutaneous (sc) formulation that provides a fixed dose of rituximab is being examined in a number of studies. Results indicat...
متن کاملSubcutaneous Vs Intravenous Administration Of Trastuzumab In Her2+ Breast Cancer Patients: A Macedonian Cost-Minimization Analysis.
BACKGROUND • The rising cost of cancer care has progressively become hardly sustainable for health care systems worldwide . • Trastuzumab (Herceptin®) humanized IgG1 monoclonal antibody is standard treatment for patients with early and with metastatic HER2-positive breast cancer. • SC-TRA, co-formulation of TRA with recombinant human hyaluronidase alternative to IV-TRA drug administration for s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Oncology Pharmacy Practice
سال: 2014
ISSN: 1078-1552,1477-092X
DOI: 10.1177/1078155214556010